Best practice of psychotropic drugs in alcoology;Du bon usage des psychotropes en alcoologie

Revue Medicale Suisse

Volumn 1, Issue 26, 2005, Pages 1734-1739

  Sutter, Karin ^a   Gache, Pascal ^a  

^a HUG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; CHLORAZEPAM; CITALOPRAM; CLOBAZAM; CLONAZEPAM; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; FLUNITRAZEPAM; FLUOXETINE; FLURAZEPAM; FLUVOXAMINE MALEATE; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; OLANZAPINE; OXAZEPAM; PAROXETINE; PRAZEPAM; PSYCHOTROPIC AGENT; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; ZOLPIDEM TARTRATE;

AGITATION; ALCOHOL WITHDRAWAL; ALCOHOLISM; COMORBIDITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFECT; DRUG USE; HUMAN; INSOMNIA; MEDICAL PRACTICE; MENTAL DISEASE; NAUSEA; PRESCRIPTION; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; SEDATION; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ALCOHOLISM; HUMANS; HYPNOTICS AND SEDATIVES; PSYCHOTROPIC DRUGS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 32944466643     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study. J Am Med Assoc 1990;264:2511-8.
2. Schneider U, Altmann A, Baumann M, et al. Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: The first multicentre study in Germany. Alcohol Alcohol 2001;36:219-23.
3. Driessen M, Meier S, Hill A, et al. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol 2001;36:249-55.
4. Kushner MG, Abrams K, Borschardt C. The relationships between anxiety disorders and alcohol use disorders: A review of major perspectives and findings. Clin Psychol Rev 2000;20:149-73.
5. Grant BF, Stinson FS, Dawso DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders. Arch Gen Psychiatry 2004;61:807-16.
6. e ed. Hazelden: Hazelden, 2002.
7. Liappas J, Paparrigopoulos T, Tzavellas E, Christodoulou G. Impact of alcohol detoxification on anxiety and depressive symptoms. Drug Alcohol Depend 2002;68:215-20.
8. e ed. Paris: Masson, 2003.
9. Stora E. Quelle approche clinique singulière du patient alcoolo-dépendant? Le journal des psychologues 2004;222:10-4.
10. Davidson KM. Diagnosis of depression in alcohol dependence: Changes in prevalence with drinking status. Br J Psychiatry 1995;166:199-204.
11. Weismann MM, Leaf PJ, Tischler GL, Blazer DG, et al. Affective Disorders in five United States Communities. Psychol Med 1980;18:141-53.
12. Raimo EB, Schuckit MA. Alcohol dependence and mood disorders. Addictive Behaviors 1998;23:933-46.
13. Torrens M, Fonseca F, Mateu G, Farre M. Efficacy of antidepressants in substance use disorders with and without comorbid depression: A systemic review and meta-analysis. Drug Alcohol Depend 2005;78:1-22.
14. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. J Am Med Assoc 2004;291:1887-96.
15. Pettinati HM. Antidepressant treatment of co-occuring depression and alcohol dependence. Biological Psychiatry 2004;56:785-92.
16. Davidson KA, Blackbun YM. Co-morbid depression and drinking outcome in those with alcohol dependence. Alcohol Alcohol 1998;33:482-7.
17. Tamam L, Ozpoyraz N. Selective serotonin reuptake inhibitor discontinuation syndrome: A review. Adv Ther 2002;19:17-26.
18. Bayard M, McIntyre J, Hill KR, Woodside J Jr. Alcohol withdrawal syndrome. Am Fam Physician 2004;69: 1443-50.
19. Daeppen JB, Gache P, Landry U, et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: A randomized treatment trial. Arch Intern Med 2002;162:1117-21.
20. Kushner MG, Sher KJ, Erickson DJ. Prospective analysis of the relation between DSM-III anxiety disorders and alcohol use disorders. Am J Psych 1999;156: 723-32.
21. Randall CL, Thomas S, Thevos AK. Concurrent alcoholism and social anxiety disorder: A first step toward developing effective treatments. Alcohol Clin Exp Res 2001;25:210-20.
22. Hutchison KE, Swift R, Rohsenow DJ, et al. Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol. Psychopharmacology 2001; 155:27-34.
23. Pirzada Sattar S, Subhash Bathia C, Petty F. Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neuroscience 2004; 29:452-7.
24. Monnelly EP, Ciraulo DA, Knapp C, Lo Castro J, Sepulveda I. Quetiapine for treatment of alcohol dependence. J Clin Psychopharmacol 2004;24:532-5.
25. Calanca A, Bryois C, Buclin T. Vade-mecum de thérapeutique psychiatrique. Genève: Ed. Médecine & Hygiène, 2001.
26. Brower KJ. Insomnia, alcoholism and relapse. Sleep Medicine Reviews 2003;7:523-9.